Catalyst Wire Dossier Catalyst Wire Dossier

Topotecan hydrochloride (Hycamtin)

topotecan hydrochloride · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topotecan hydrochloride (Hycamtin), covering 2016-01-14 to 2016-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 2]

See pricing